Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127070501 | 12707050 | 1 | I | 20110108 | 20110113 | 20160901 | 20160901 | EXP | US-PFIZER INC-2011008242 | PFIZER | 68.00 | YR | M | Y | 86.60000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127070501 | 12707050 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | 18989 | TABLET | |||||||||
| 127070501 | 12707050 | 2 | C | MECLOZINE HYDROCHLORIDE | MECLOZINE DIHYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 3 | C | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 5 | C | NIASPAN | NIACIN | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 6 | C | AVALIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 7 | C | TRICOR | FENOFIBRATE | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 8 | C | AVANDIA | ROSIGLITAZONE MALEATE | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 10 | C | POLYSACCHARIDE-IRON COMPLEX | 2 | Oral | UNK | 0 | |||||||||||
| 127070501 | 12707050 | 11 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 12 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 13 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | UNK | 0 | ||||||||||
| 127070501 | 12707050 | 14 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127070501 | 12707050 | 1 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127070501 | 12707050 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127070501 | 12707050 | Chest pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127070501 | 12707050 | 1 | 20100525 | 0 | ||
| 127070501 | 12707050 | 2 | 20100419 | 0 | ||
| 127070501 | 12707050 | 3 | 20080606 | 0 | ||
| 127070501 | 12707050 | 4 | 20080606 | 0 | ||
| 127070501 | 12707050 | 5 | 20080606 | 0 | ||
| 127070501 | 12707050 | 6 | 20080606 | 0 | ||
| 127070501 | 12707050 | 7 | 20080606 | 0 | ||
| 127070501 | 12707050 | 8 | 20080606 | 0 | ||
| 127070501 | 12707050 | 9 | 20090206 | 0 | ||
| 127070501 | 12707050 | 10 | 20090610 | 0 | ||
| 127070501 | 12707050 | 11 | 20090527 | 0 | ||
| 127070501 | 12707050 | 12 | 20080303 | 0 | ||
| 127070501 | 12707050 | 13 | 20080303 | 0 | ||
| 127070501 | 12707050 | 14 | 20110106 | 0 |